These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25095684)

  • 1. [Metabolic status and bone mineral density in patients with pseudarthrosis of long bones in hyperhomocysteinemia].
    Bezsmertnyĭ IuO
    Lik Sprava; 2013 Jun; (4):44-51. PubMed ID: 25095684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The frequency of endothelial dysfunction in patients with pseudarthrosis of long bones with hyperhomocysteinemia and associated metabolic disorder].
    Bezsmertnyĭ IuO
    Lik Sprava; 2013; (3):48-53. PubMed ID: 25016746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone health and multiple sclerosis.
    Dobson R; Ramagopalan S; Giovannoni G
    Mult Scler; 2012 Nov; 18(11):1522-8. PubMed ID: 22740489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome.
    Hermus AR; Smals AG; Swinkels LM; Huysmans DA; Pieters GF; Sweep CF; Corstens FH; Kloppenborg PW
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2859-65. PubMed ID: 7559865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocysteinemia due to levodopa treatment as a risk factor for osteoporosis in patients with Parkinson's disease.
    Lee SH; Kim MJ; Kim BJ; Kim SR; Chun S; Kim HK; Ryu JS; Kim GS; Lee MC; Chung SJ; Koh JM
    Calcif Tissue Int; 2010 Feb; 86(2):132-41. PubMed ID: 20049422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin K deficiency evaluated by serum levels of undercarboxylated osteocalcin in patients with anorexia nervosa with bone loss.
    Urano A; Hotta M; Ohwada R; Araki M
    Clin Nutr; 2015 Jun; 34(3):443-8. PubMed ID: 24909585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [characteristics of the bone tissue metabolism in adolescents with the connective tissue's undifferentiated dysplasia].
    Khokhlova OI; Kalaeva GIu; Ust'iantseva IM
    Fiziol Cheloveka; 2014; 40(3):101-8. PubMed ID: 25702465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people.
    Dhonukshe-Rutten RA; Pluijm SM; de Groot LC; Lips P; Smit JH; van Staveren WA
    J Bone Miner Res; 2005 Jun; 20(6):921-9. PubMed ID: 15883631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective review of serum and urinary lithogenic risk factors in patients with osteoporosis and osteopenia.
    Arrabal-Polo MA; Girón-Prieto MS; Cano-García Mdel C; Poyatos-Andujar A; Quesada-Charneco M; Abad-Menor F; Arias-Santiago S; Zuluaga-Gomez A; Arrabal-Martin M
    Urology; 2015 Apr; 85(4):782-5. PubMed ID: 25817102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental hyperhomocysteinemia disturbs bone metabolism in rats.
    Ozdem S; Samanci S; Tasatargil A; Yildiz A; Sadan G; Donmez L; Herrmann M
    Scand J Clin Lab Invest; 2007; 67(7):748-56. PubMed ID: 17852810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid induced osteopenia in cancellous bone of sheep: validation of large animal model for spine fusion and biomaterial research.
    Ding M; Cheng L; Bollen P; Schwarz P; Overgaard S
    Spine (Phila Pa 1976); 2010 Feb; 35(4):363-70. PubMed ID: 20110841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alendronate reduces serum TNFalpha and IL-1beta, increases neutrophil counts, and improves bone mineral density and bone metabolism indices in patients with chronic idiopathic neutropenia (CIN)-associated osteopenia/osteoporosis.
    Papadaki HA; Tsatsanis C; Christoforidou A; Malliaraki N; Psyllaki M; Pontikoglou C; Miliaki M; Margioris AN; Eliopoulos GD
    J Bone Miner Metab; 2004; 22(6):577-87. PubMed ID: 15490268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
    Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metabolic bone disease in premature infants and genetic polymorphisms].
    Funke S; Morava E; Czakó M; Vida G; Ertl T; Kosztolányi G
    Orv Hetil; 2007 Oct; 148(41):1957-65. PubMed ID: 17921123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of bone mineral density in stable kidney transplant recipients.
    Gupta AK; Huang M; Prasad GV
    J Nephrol; 2012; 25(3):373-83. PubMed ID: 21928224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Methylenetetrahydrofolate reductase polymorphism C677T in patients with consolidated fractures and pseudarthrosis of long bones: relationship with homocystein and inflammatory mediators].
    Bezsmertnyĭ IuO
    Lik Sprava; 2013; (5):54-9. PubMed ID: 24605633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired development of bone mineral density during chemotherapy: a prospective analysis of 46 children newly diagnosed with cancer.
    Arikoski P; Komulainen J; Riikonen P; Parviainen M; Jurvelin JS; Voutilainen R; Kröger H
    J Bone Miner Res; 1999 Dec; 14(12):2002-9. PubMed ID: 10620058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-level lifetime exposure to cadmium decreases skeletal mineralization and enhances bone loss in aged rats.
    Brzóska MM; Moniuszko-Jakoniuk J
    Bone; 2004 Nov; 35(5):1180-91. PubMed ID: 15542044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective study of histomorphometry, biochemical bone markers and bone densitometric response to pamidronate in β-thalassaemia presenting with osteopenia-osteoporosis syndrome.
    Chatterjee R; Shah FT; Davis BA; Byers M; Sooranna D; Bajoria R; Pringle J; Porter JB
    Br J Haematol; 2012 Nov; 159(4):462-71. PubMed ID: 22966867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry.
    Eriksen EF; Charles P; Melsen F; Mosekilde L; Risteli L; Risteli J
    J Bone Miner Res; 1993 Feb; 8(2):127-32. PubMed ID: 8442431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.